Clinical Trials Directory

Trials / Completed

CompletedNCT01046565

Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

Split-Face Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the tolerability of Differin® (adapalene) Cream, 0.1% to Differin® Lotion, 0.1% in subjects with healthy skin treated once a day for three (3) weeks.

Conditions

Interventions

TypeNameDescription
DRUGadapalene cream 0.1%adapalene cream 0.1% - apply once daily on one side of the face for 3 weeks
DRUGadapalene lotion 0.1%adapalene lotion 0.1% - apply once daily on the opposite side of the face for 3 weeks

Timeline

Start date
2010-01-01
Primary completion
2010-02-01
Completion
2010-02-01
First posted
2010-01-12
Last updated
2022-08-25
Results posted
2011-05-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01046565. Inclusion in this directory is not an endorsement.